The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review

Salarvand, Shahin; Hemati, Simin; Adibi, Payman; Taleghani, Fariba

doi:10.4081/oncol.2018.359

Cited by 5 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Applying the definition of rehabilitation was difficult because the papers' text frequently mentioned little more than the diagnostic group or health problems dealt with in the CPGs evaluated. (1) Full title of the CPG (2) Bibliographic reference (3) Developing group, organization or authority (4) Year of publication (5) Geographic or political entity for which the CPG was written (eg, "Brazil") (6) The qualifications of the CPG's authors (7) The nature of the CPG's intended users (8) The 6 AGREE II domain scores, if provided, and their mean, SD, and median across CPGs, if given. (9) The 23 AGREE II item scores, if provided, and their mean, SD, and median across CPGs, if given.…”

Section: List Of Abbreviationsmentioning

confidence: 99%

Quality of Rehabilitation Clinical Practice Guidelines: An Overview Study of AGREE II Appraisals

Dijkers

Ward

Annaswamy

et al. 2020

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

To evaluate the quality of rehabilitation Clinical Practice Guidelines (CPG), specifically with respect to their applicability. Data Sources: The Medline, Embase, Web of Science, CINAHL, PsycINFO, and Cochrane Library databases were searched for papers published between 2017 and 2019 that applied the Appraisal of Guidelines for Research & Evaluation II (AGREE II) CPG quality assessment tool to rehabilitation CPGs. Study Selection: Deduplicated abstracts (NZ449) were independently screened by 2 authors, resulting in 47 articles. Independent screening of 47 full texts by 2 authors resulted in a final selection of 40 papers appraising 544 CPGs. Data Extraction: Data were extracted by 1 author using a pretested Excel form and were checked by a second author. Key data on the review papers included: purpose, methods used for finding and appraising CPGs, and observations and conclusions on CPG quality, specifically applicability. Key data on each CPG included the 6 AGREE II domain scores or 23 item scores, as well as 2 global evaluations. Data Synthesis: The mean AGREE II domain scores for the 544 CPGs (all on a 0-100 scale) were: scope and purpose (72), stakeholder involvement (53), rigor of development (56), clarity of presentation (71), applicability (34), and editorial independence (50). Only 36% of CPGs were recommended without modification. The 40 review authors generally stated that all or most of the CPGs they appraised were poor or mediocre, especially with respect to applicability. They only infrequently pointed out what information, going beyond that specified in AGREE II, would enhance applicability. Conclusions: CPGs in principle are an ideal means to move knowledge obtained from clinical research into practice. Our review of reviews of rehabilitation CPGs shows that they commonly have deficits, especially in terms of applicability. Much work needs to be done by guideline developers to make it easier for the average rehabilitation organization and clinician to implement CPGs in daily practice.

show abstract

Section: List Of Abbreviationsmentioning

confidence: 99%

Quality of Rehabilitation Clinical Practice Guidelines: An Overview Study of AGREE II Appraisals

Dijkers

Ward

Annaswamy

et al. 2020

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

show abstract

“…(2) It is one of the most common malignancies in the world and unfortunately has been increasing in Iranian women. (3,4) Diagnosis and treatment of breast cancer have a significant impact on the lives of patients and their families. Women with breast cancer experience a lot of psychological disorder .…”

Section: Introductionmentioning

confidence: 99%

Comparison of anxiety, depression, and quality of life of husbands of women with and without breast cancer

Vizeshfar¹,

Dehghanrad²,

MAGHAREİ³

2023

J Exp Clin Med

View full text Add to dashboard Cite

The aim of this study was to compare the anxiety, depression, and quality of life of husbands of women with breast cancer referred to the chemotherapy clinic with husbands of non-affected wives. This was a case-control study, with purposive-convenience sampling method. 190 husbands of patients with or without breast cancer participate in this study. Data collection tools included a four-part questionnaire, consisted of demographic characteristics, shortened form of quality of life questionnaire, Beck depression inventory, and Beck anxiety inventory. In the areas of social relations and living environment (QolD3, QolD4), a statistically significant difference was found between the two groups in quality of life (p-value < 0.001). Pearson correlation coefficient showed a statistically significant difference in the case group between the history of chemotherapy and mean anxiety score (p-value < 0.001), and quality of life with number of children (p-value < 0.002). The findings of this study showed that in addition to giving attention to the patients, attention to health needs and quality of life of their spouses is also a priority.

show abstract

“…Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect, with sensory symptoms being pain, tingling, allodynia or numbness. Thus far, there has been no effective treatment for this condition; however, different techniques are being investigated [7][8][9][10][11]. CIPN is dose-limiting toxicity experienced by up to 40% of patients who receive neurotoxic chemotherapy.…”

Section: Introductionmentioning

confidence: 99%

Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review

et al. 2022

View full text Add to dashboard Cite

Transcutaneous electrical nerve stimulation (TENS) is the usage of a mild electrical current through electrodes that stimulate nerves. Patients with malignancies experience pain and chemotherapy-induced peripheral neuropathy. A systematic review was performed to find research evaluating the effect of TENS on these two common symptoms decreasing the quality of life in cancer patients. PubMed, the Cochrane Central Register of Controlled Trials and EMBASE were searched. Original studies, namely randomized controlled trials, quasi-randomized controlled trials and controlled clinical trials, published between April 2007 and May 2020, were considered. The quality of the selected studies was assessed. Seven papers were incorporated in a qualitative synthesis, with 260 patients in total. The studies varied in terms of design, populations, endpoints, quality, treatment duration, procedures and follow-up period. Based on the results, no strict recommendations concerning TENS usage in the cancer patient population could be issued. However, the existing evidence allows us to state that TENS is a safe procedure that may be self-administered by the patients with malignancy in an attempt to relieve different types of pain. There is a need for multi-center, randomized clinical trials with a good methodological design and adequate sample size.

show abstract

The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review

Cited by 5 publications

References 29 publications

Quality of Rehabilitation Clinical Practice Guidelines: An Overview Study of AGREE II Appraisals

Quality of Rehabilitation Clinical Practice Guidelines: An Overview Study of AGREE II Appraisals

Comparison of anxiety, depression, and quality of life of husbands of women with and without breast cancer

Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review

Contact Info

Product

Resources

About